Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Prospective Observational Study of Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00161668

Enrollment

500

Registered

2005-09-12

Start date

2001-10-31

Completion date

Unknown

Last updated

2007-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myeloid Leukemia

Keywords

Leukemia

Brief summary

This study is designed to assess the safety of Mylotarg therapy in routine practice.

Interventions

DRUGMylotarg

Study design

Observational model

DEFINED_POPULATION

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Treated by Mylotarg * Provide ICF

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026